Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) closed at $16.54 up 1.04% from its previous closing price of $16.37. In other words, the price has increased by $1.04 from its previous closing price. On the day, 1.65 million shares were traded. ACAD stock price reached its highest trading level at $17.09 during the session, while it also had its lowest trading level at $16.52.
Ratios:
For a deeper understanding of Acadia Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.74. For the most recent quarter (mrq), Quick Ratio is recorded 2.11 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
On August 07, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $28 to $20.
On June 27, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $31.BMO Capital Markets initiated its Outperform rating on June 27, 2024, with a $31 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 19 ’24 when Teehan Brendan sold 10,329 shares for $16.81 per share. The transaction valued at 173,630 led to the insider holds 62,105 shares of the business.
Kihara James sold 4,073 shares of ACAD for $68,467 on Nov 19 ’24. The PRINCIPAL ACCOUNTING OFFICER now owns 19,863 shares after completing the transaction at $16.81 per share. On Nov 19 ’24, another insider, Schneyer Mark C., who serves as the EVP, CHIEF FINANCIAL OFFICER of the company, sold 10,259 shares for $16.81 each. As a result, the insider received 172,454 and left with 53,302 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACAD now has a Market Capitalization of 2752123904 and an Enterprise Value of 2236161792. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.41, and their Forward P/E ratio for the next fiscal year is 21.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.00 while its Price-to-Book (P/B) ratio in mrq is 4.77. Its current Enterprise Value per Revenue stands at 2.406 whereas that against EBITDA is 17.955.
Stock Price History:
Over the past 52 weeks, ACAD has reached a high of $32.59, while it has fallen to a 52-week low of $14.15. The 50-Day Moving Average of the stock is 5.90%, while the 200-Day Moving Average is calculated to be -3.83%.
Shares Statistics:
For the past three months, ACAD has traded an average of 1.35M shares per day and 1370500 over the past ten days. A total of 164.65M shares are outstanding, with a floating share count of 164.29M. Insiders hold about 1.26% of the company’s shares, while institutions hold 93.84% stake in the company. Shares short for ACAD as of 1730332800 were 9532729 with a Short Ratio of 7.04, compared to 1727654400 on 7979555. Therefore, it implies a Short% of Shares Outstanding of 9532729 and a Short% of Float of 7.739999999999999.
